Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Canada Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20021
20033
20044
20053
200611
20077
20086
20094
20105
20114
20128
20131
20145
20155
20164
20173
20183
20197
202013
20218
20225
20234
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Terminated23
Active, not recruiting16
Recruiting13
Unknown status3
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto18
GlaxoSmithKline9
National Cancer Institute (NCI)9
British Columbia Cancer Agency7
Sunnybrook Health Sciences Centre7
M.D. Anderson Cancer Center6
Merck Sharp & Dohme LLC6
AstraZeneca5
University of British Columbia5
Gynecologic Oncology Group4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms136
Endometrial Neoplasms25
Ovarian Neoplasms20
Uterine Cervical Dysplasia17
Squamous Cell Carcinoma of Head and Neck15
Stomach Neoplasms15
Neoplasms13
Papillomavirus Infections13
Carcinoma, Non-Small-Cell Lung12
Breast Neoplasms11

Trials

Showing 76 to 100 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.